Valbiotis


Developer of plant- and marine-derived dietary supplements focused on cardiometabolic health, women's health and dermo-cosmetic applications. The company conducts randomized clinical testing of formulations, develops multi-ingredient oral dosage forms (powders, capsules, tablets), sources sustainable raw materials, and distributes products via direct-to-consumer e-commerce and pharmacy outlets. Product design and R&D activities are reported as based in France.

Industries

Biotechnology
Clinical Trials
Product Research
Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)

Valbiotis


Patents

Composition comprising a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum and use to act on carbohydrate and/or fat metabolism

US-12011474-B2

View Details

Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases

US-11712056-B2

View Details

Composition comprising a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum and use to act on carbohydrate and/or fat metabolism

US-10813965-B2

View Details

Compositions and methods for controlling carbohydrate and fat metabolism

US-10736930-B2

View Details

Compositions and methods for controlling carbohydrate and fat metabolism

US-10232005-B2

View Details

Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism

US-9962420-B2

View Details

Products

Collagène marin Articulations

Powder supplement containing hydrolyzed marine collagen peptides at a high daily dose combined with complementary actives (glucosamine, harpagophytum, vitamin C and magnesium) formulated to support joint comfort and mobility.

Collagène marin Beauté

Powder supplement delivering hydrolyzed low-molecular-weight marine collagen peptides at clinical dosing combined with hyaluronic acid and antioxidant vitamins to target skin hydration, firmness and radiance.

Ménopause & Périménopause

Oral supplement combining multiple non-hormonal actives (botanical extracts, amino acids and vitamins) formulated to alleviate menopausal and perimenopausal symptoms such as hot flashes, mood changes and fatigue.

Sérénité

Tablet supplement formulated with adaptogenic and calming botanicals, magnesium and vitamin B6 to support stress management and emotional balance.

Sommeil

Tablet supplement combining melatonin with plant extracts, magnesium and vitamin B6 to support sleep initiation and quality without dependence.

Magnésium

Supplement combining three bioavailable forms of magnesium (bisglycinate, glycero‑phosphate and malate) with vitamin B6 to address magnesium insufficiency and support energy, nervous system and muscle function.

View All Products

Expertise Areas

  • Clinical trial management for nutraceuticals
  • Plant-extract chemistry and standardization
  • Hydrolyzed marine collagen formulation and clinical testing
  • Micronutrient and multi-form magnesium formulation
  • Show More (5)

Key Technologies

  • Randomized double-blind placebo-controlled clinical study design
  • Hydrolyzed low-molecular-weight collagen peptides
  • Plant-extract standardization and polyphenol complexation
  • High-dose oral powder formulation
  • Show More (4)

News & Updates

Article summarizing evidence and mechanisms by which marine collagen peptides can support skin hydration, firmness and the appearance of hair and nails; published on the company website.

Reported clinical testing of a patented plant-extract complex on fasting glycemia, triglycerides and waist circumference in studies involving several hundred participants (reported N up to 735).

Reported randomized clinical testing of a plant-extract formulation for blood pressure and circulatory endpoints in studies involving approximately 520 participants.

Two randomized, double-blind clinical studies referenced on the product page evaluating marine collagen peptides at clinical doses (examples: trials with 40 and 57 subjects comparing peptide doses to placebo over 12 weeks).

Reference to a pilot randomized placebo-controlled clinical study evaluating specific marine collagen peptides for knee osteoarthritis symptoms (previously referenced on company product pages).


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.